Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.143 (
poly(ADP-ribose) glycohydrolase
)
208
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
TRPM2
cation channels are widely expressed in the immune system and are thought to play a role in immune cell responses to oxidative stress. Patch clamp analyses suggest that
TRPM2
channel activation can occur through a direct action of oxidants on
TRPM2
channels or indirectly through the actions of a related group of adenine nucleotide 2nd messengers. However, the contribution of each gating mechanism to oxidative stress-induced
TRPM2
activation in lymphocytes remains undefined. To better understand the molecular events leading to
TRPM2
activation in lymphocytes, we analyzed oxidative stress-induced turnover of intracellular NAD, the metabolic precursor of adenine nucleotide 2nd messengers implicated in
TRPM2
gating, and oxidative stress-induced
TRPM2
-mediated currents and Ca2+ transients in DT40 B cells.
TRPM2
-dependent Ca2+ entry did not influence the extent or time course of oxidative stress-induced turnover of NAD. Furthermore, expression of oxidative stress-activated poly(ADP-ribose) polymerases (PARPs) was required for oxidative stress-induced NAD turnover,
TRPM2
currents, and
TRPM2
-dependent Ca2+ transients; no oxidant-induced activation of
TRPM2
channels could be detected in PARP-deficient cells. Together, our results suggest that during conditions of oxidative stress in lymphocytes,
TRPM2
acts as a downstream effector of the PARP/
poly(ADP-ribose) glycohydrolase
pathway through PARP-dependent formation of ADP-ribose.
...
PMID:The Poly(ADP-ribose) polymerase PARP-1 is required for oxidative stress-induced TRPM2 activation in lymphocytes. 1859 83